EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Draw on advantages and avoid disadvantages: CT-derived individualized radiomic signature for predicting chemo-radiotherapy sensitivity in unresectable advanced non-small cell lung cancer

Liping Yang, Mengyue Li, Yixin Liu, Zhiyun Jiang, Shichuan Xu, Hongchao Ding, Xing Gao, Shilong Liu, Lishuang Qi, Kezheng Wang

Journal of Cancer Research and Clinical Oncology · 2024

DOI: 10.1007/s00432-024-05971-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Liping Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: PET-CT/MR Department, Harbin Medical University Cancer Hospital, Harbin, 150001, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Chemoradiotherapy, Tomography, X-Ray Computed. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hai Yan Fund of The Third Affiliated Hospital of Harbin Medical University, National Natural Science Foundation of China, National Undergraduate Innovation and Entrepreneurship Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsChemoradiotherapyTomography, X-Ray ComputedPrecision MedicineHumansFemaleMaleRetrospective StudiesMiddle AgedAgedAdultAged, 80 and overPrognosisRadiomics

Stichwörter der Autor:innen

Bioinformatic analysesConcurrent chemo-radiotherapyNon-small cell lung cancerQualitativeRadiomics

Autor:innen und Institutionen

  • PET-CT/MR Department, Harbin Medical University Cancer Hospital, Harbin, 150001, People's Republic of China.
  • College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150001, People's Republic of China.
  • Department of Equipment, The Second Hospital of Harbin, Harbin, People's Republic of China.
  • Department of Physical Diagnosis, Heilongjiang Provincial Hospital, Harbin, People's Republic of China.
  • Department of Thoracic Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, 150001, People's Republic of China. liushilong1984@hrbmu.edu.cn.
  • College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150001, People's Republic of China. qilishuang7@ems.hrbmu.edu.cn.

Förderung

  • Hai Yan Fund of The Third Affiliated Hospital of Harbin Medical University
  • National Natural Science Foundation of China
  • National Undergraduate Innovation and Entrepreneurship Training Program
  • Provincial Key Research and Development Program of Heilongjiang Province

Zitieren

APA

Yang, L., Li, M., Liu, Y., Jiang, Z., Xu, S., Ding, H., Gao, X., Liu, S., Qi, L., & Wang, K. (2024). Draw on advantages and avoid disadvantages: CT-derived individualized radiomic signature for predicting chemo-radiotherapy sensitivity in unresectable advanced non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05971-4

Vancouver

Yang L, Li M, Liu Y, Jiang Z, Xu S, Ding H, et al. Draw on advantages and avoid disadvantages: CT-derived individualized radiomic signature for predicting chemo-radiotherapy sensitivity in unresectable advanced non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05971-4

BibTeX
@article{Yang2024,
  author = {Yang, Liping and Li, Mengyue and Liu, Yixin and Jiang, Zhiyun and Xu, Shichuan and Ding, Hongchao and Gao, Xing and Liu, Shilong and Qi, Lishuang and Wang, Kezheng},
  title = {Draw on advantages and avoid disadvantages: CT-derived individualized radiomic signature for predicting chemo-radiotherapy sensitivity in unresectable advanced non-small cell lung cancer},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  doi = {10.1007/s00432-024-05971-4}
}
Kostenlos starten →